The Immunology, Cardiovascular, Fibrosis, and Global Health (ICFG) Thematic Research Center (TRC) at BMS is one of the fundamental Research and Early Development (R&ED) units delivering therapeutics to patients. Our mission is to create transformative medicines of tomorrow based on the cutting-edge science of today. We leverage BMS’s internal invention of engine that includes industry-leading expertise in small molecule chemistry, protein biotherapeutics, cell therapy, protein degradation, nucleic acids, and other therapeutic modalities. We work closely our R&ED colleagues in clinical and non-clinical development, project leadership, translational medicine, and informatics to advance therapies based on a deep understand of causal human biology. Further, we collaborate across the biopharmaceutical ecosystem to establish partnerships that complement our internal expertise.
We are currently seeking a highly motivated in vivo scientist with expertise in immunology, inflammation, and autoimmune diseases to join our Immunology & Inflammation Discovery Biology group in Cambridge, MA. The successful candidate must have hands on expertise in executing on rodent models of disease. Experience working with infection models of autoimmune diseases, such as Atopic Dermatitis and Inflammatory Bowel Disease, is desirable. This individual will interact seamlessly with other scientists and functional groups within a drug discovery team to formulate and implement the in vivo strategy for the programs in the Immunoscience Portfolio. The focus of this position will be the in vivo evaluation of novel therapeutic agents that will support these drug discovery efforts, additional responsibilities include the identification and validation of novel disease and target specific biomarkers, and the development of new pharmacodynamic/disease models and end-points for autoimmune indications. Other responsibilities include but are not limited to prepare, review and deliver scientific presentations to internal and external stakeholders; interact with senior management and key opinion leaders.
For more information and to apply click HERE